The immunotherapy revolution
Immunotherapy has revolutionized cancer treatment--but not for everyone. See how UChicago researchers are overcoming these barriers to help more patients. [Read More]
clinical trials
Study adds diabetes drug to current state-of-the-art therapy for patients with ovarian cancer
The University of Chicago Medicine is leading a clinical trial that will add metformin, a drug commonly used for type II diabetes, to the most effective current therapy for patients with stage 3 or stage 4 ovarian cancer. [Read More]
Puppy Love: Meet Milo, a Portuguese Water Dog with a nose for research
Meet Milo, a shaggy, 2-year-old service dog who is helping University of Chicago researchers study how pets can reduce stress levels in patients. [Read More]
Designing a better clinical trial to sort out complex tumors
Oncologist Daniel Catenacci designed a "supercontinent" of clinical trials to find the best treatments for patients with esophageal and gastric cancers. [Read More]
UCM trial of early physical and occupational therapy named one of top-15 physiotherapy trials ever
A UChicago clinical trial of early physical and occupational therapy in critically ill patients has been selected as one of the 15 most significant physiotherapy trials ever published. [Read More]
UChicago Medicine and Advocate receive NIH grant to establish Type 1 Diabetes TrialNet center
The $1.2 million grant will establish the first Type 1 Diabetes TrialNet Clinical Center in Chicago, to identify people at risk or in the early stages of type 1 diabetes and offer them the chance to participate in clinical studies. [Read More]
Dimon in the Rough
The optimism for recovery surrounding J.P. Morgan CEO Jamie Dimon's public diagnosis of throat cancer highlights the advances made in treating head and neck cancers. [Read More]
University Of Chicago Chosen As A Center For New Cancer Clinical Trials Network
A team from the University of Chicago Medicine Comprehensive Cancer Center will serve as a Lead Academic Participating Site for the newly created National Clinical Trials Network (NCTN). [Read More]
The Power of Mobilizing the Immune System for Cancer Therapy
Heralded as the “Breakthrough of 2013” by the leading scientific journal Science, cancer immunotherapy is finally getting the attention many in the field thought it long deserved. [Read More]
Cancer Research Roundup: Child Care and Treatment, IBD-associated Colorectal Cancer, Ibrutinib, and Glioblastoma
The latest roundup of cancer research from UChicago highlights: a study showing how young mothers with breast cancer often don't follow through with needed radiation therapy; a link between inflammatory bowel disease and colorectal cancer; Ibrutinib's work at limiting cell proliferation in chronic lymphocytic leukemia; a prognostic tool for neuroblastoma; and testing bevacizumab in glioblastoma. [Read More]
